Trials / Completed
CompletedNCT00717769
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 270 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to explore the efficacy and safety of SUN13834 vs placebo in adult participants with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SUN13834 | Low dose, orally 3 times a day (tid) for 28 days of SUN13834 |
| DRUG | Placebo | Placebo, orally (tid) for 28 days of SUN13834 |
Timeline
- Start date
- 2008-07-16
- Primary completion
- 2009-04-09
- Completion
- 2009-04-09
- First posted
- 2008-07-17
- Last updated
- 2021-04-21
- Results posted
- 2021-04-21
Locations
28 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00717769. Inclusion in this directory is not an endorsement.